FFTY
Innovator IBD 50 ETF
The Innovator IBD 50 Fund is an active fund that takes the constituents of the IBD 50 Index and reweights them from price-weighted to a proprietary method based on specific fundamental and technical indicators. It holds US-listed stocks and ADRs.
US
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 58.6 M
ASSETS UNDER MGMT
80 bp
EXPENSES
Fund Basics
| Inception date | Apr 08, 2015 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Annually |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | Yes |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| OKEANIS ECO TANKERS CORP | 4.0 % |
| RUBRIK INC-A | 3.8 % |
| HINGE HEALTH INC-A | 3.6 % |
| DORIAN LPG LTD | 3.6 % |
| SOUTHERN COPPER CORP | 3.6 % |
| ERO COPPER CORP. | 3.5 % |
| HALOZYME THERAPEUTICS INC | 3.4 % |
| AURA MINERALS INC | 3.4 % |
| ADVANCED MICRO DEVICES | 3.4 % |
| LUMENTUM HOLDINGS INC | 3.4 % |
Constituent Breakdown
| Number of holdings | 49 |
| Herfindahl-Hirschman Index | 279 |
| Wgt avg mkt cap (mns) | $273,378 |
| Large cap (>$10bn) | 60.4% |
| Mid cap ($2-10bn) | 34.4% |
| Small cap (<$2bn) | 3.3% |
| Developed mkts. | 95.2% |
| Emerging mkts. | 2.9% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 88.2 % |
 |
CANADA | 5.5 % |
 |
TAIWAN | 2.0 % |
 |
CHINA | 0.9 % |
 |
BRITAIN | 0.5 % |
Historical Performance
Standardized Performance (as of 09/30/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 0.0% | -6.8% | 13.8% | 15.9% | -6.0% | 4.0% | -- | 2.9% |
| Dividend Yield | 0.0% | 0.0% | 0.5% | 0.6% | 0.8% | 0.5% | -- | 0.4% |
| Total Returns | 0.0% | -6.8% | 14.3% | 16.5% | -5.1% | 4.5% | -- | 3.3% | Ann. Volatility | 35.6% | 36.1% | 34.0% | 30.8% | 29.6% | 27.9% | -- | 26.9% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 2.01 | 52% |
| MSCI EAFE | 1.48 | 42% |
| MSCI Emg Mkts | 1.04 | 53% |
Liquidity Measures
| Avg. volume (000) | 20 |
| ADV traded (mns) | $1 |
| Turnover | 1.1% |
| Avg. Bid/Ask (% of price) | 0.24% |
Technical Indicators
| 30d moving avg. (EMA) | $38.16 |
| Relative strength (RSI) | 47 |
| MACD/Signal | -0.61/-0.77 |
| Bollinger Bands (Upper/Lower) | $38.48/$36.33 |
| Short interest (% of AUM) | 1.3% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. FFTY |
Expenses vs. FFTY |
ALTAR Score™ vs. FFTY |
|---|---|---|---|---|
| BOUT | Innovator IBD Breakout Opportunities ETF | 34.2% | +1 bp | -1.2% |
| ALAI | Alger AI Enablers & Adopters ETF | 26.7% | -25 bp | +0.7% |
| FFOG | Franklin Focused Growth ETF | 22.6% | -19 bp | +1.9% |
| JTEK | JPMorgan U.S. Tech Leaders ETF | 21.3% | -15 bp | -1.0% |
| FMTM | MarketDesk Focused U.S. Momentum ETF | 20.8% | -35 bp | +2.5% |
| TMAT | Main Thematic Innovation ETF | 20.0% | +84 bp | -0.2% |
| ARTY | iShares Future AI & Tech ETF | 19.8% | -33 bp | +1.4% |
| CHAT | Roundhill Generative AI & Technology ETF | 19.6% | -5 bp | +1.5% |
| GFLW | VictoryShares Free Cash Flow Growth ETF | 19.6% | -41 bp | +2.5% |
| IQM | Franklin Intelligent Machines ETF | 19.4% | -30 bp | +0.8% |
Risk and Returns: FFTY vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 10/24/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
2.1%
ALTAR SCORE™
5th
PERCENTILE
AVOID
ETFRC RATING
There are 1,377 funds in the US Equity category with an average
ALTAR Score™ of 5.5% and a standard deviation
of 2.1%. FFTY's ALTAR Score™ is approximately -1.6 standard
deviations above the category average. This places FFTY in the 5th percentile
among funds in the category.
Sell-Side Consensus
$38.72
PRICE TARGET
+15.7%
UPSIDE